Last updated: March 2, 2026
What is NDC 60687-0735?
NDC 60687-0735 refers to a proprietary drug product whose specifics are identified within the National Drug Code (NDC) system. Based on available public data, this code tracks a biologic or small molecule used for a specific therapeutic indication. Precise details about the drug's name, manufacturer, and indication are necessary for a comprehensive analysis.
Note: The exact product details are subject to confirmation, as NDC database updates and proprietary formulations may not be publicly accessible. For thorough analysis, acquiring the product's label, patent status, and regulatory filings is essential.
Market Overview
Therapeutic Area
The likely therapeutic classification depends on the drug's intended use, which could span oncology, autoimmune disorders, infectious diseases, or rare conditions. The market size is influenced by:
- Incidence/prevalence of conditions treated
- Competition landscape
- Price points of comparable therapies
Competitive Landscape
The competitive environment includes:
- Original biologics or small molecules targeting the same condition
- Biosimilars or generics entering the market
- Market entry barriers, including patent exclusivity and regulatory hurdles
Regulatory Status
- Approved by FDA or other drug agencies
- Pending approvals or regulatory filings
- Patent status, exclusivity periods, and patent cliffs
Distribution Channels
- Hospitals and specialty clinics
- Retail pharmacies for small molecules
- Health systems with infusion centers for biologics
Price Projections
Current Price Benchmarks
Prices vary based on formulation, dosing, and regulatory approval:
| Product Type |
Typical Price Range per Unit |
Remarks |
| Biologics |
$2,000 - $15,000 per dose |
Peak prices, highly dependent on indication and market exclusivity |
| Small molecules |
$100 - $2,000 per treatment course |
Lower, with broader generic competition |
Future Price Trends
Factors influencing future pricing include:
- Patent expiration timelines
- Entry of biosimilars or generics
- Manufacturing cost reductions
- Payer negotiations and reimbursement policies
- Market penetration strategies
Price Projection Methodology
Using comparable data from similar drugs, the following projections are set:
- Short-term (0-2 years): Price remains stable, with premiums for exclusivity. For biologics, expect prices around $8,000 - $12,000 per dose.
- Medium-term (3-5 years): Potential price erosion due to biosimilar entry, estimated at 20-50%, reducing prices to $4,000 - $8,000.
- Long-term (beyond 5 years): Additional biosimilar or generic competition could further reduce prices by 50% or more; prices could fall below $4,000 per dose.
Revenue Potential
Assuming annual sales volumes and list prices:
| Scenario |
Sales Volume |
Price per Dose |
Estimated Revenue |
| Conservative (biosimilar market share 10%) |
1,000 units |
$12,000 |
$12 million |
| Moderate (market share 25%) |
2,500 units |
$8,000 |
$20 million |
| Aggressive (market share 50%) |
5,000 units |
$4,000 |
$20 million |
Key Factors Affecting Market and Price
- Patent expirations scheduled within 5-10 years
- Regulatory approvals in international markets
- Adoption speed by healthcare providers
- Reimbursement levels negotiated with payers
- Development of lower-cost biosimilars or generics
- Manufacturing costs and supply chain stability
Risks and Opportunities
Risks:
- Patent litigation delays
- Regulatory hurdles extending approval timelines
- Generics or biosimilar market entry reducing prices
- Reimbursement restrictions
Opportunities:
- First-to-market advantage if patent exclusivity is maintained
- Expansion into new therapeutic indications
- International market expansion
Key Takeaways
- The product's market size hinges on the therapeutic indication and competitive landscape.
- Short-term pricing likely remains high, with biologics priced above $8,000 per dose.
- Biosimilar and generic competition are primary drivers of price erosion after patent expiry.
- Revenue projections vary widely based on market penetration and competitive dynamics.
- Monitoring patent timelines, regulatory milestones, and market entry strategies is critical for accurate forecasting.
FAQs
1. How soon could biosimilars impact drug prices?
Typically within 4-8 years post-patent expiry, depending on regulatory approval and market acceptance.
2. What factors determine the drug's market exclusivity?
Patent length, regulatory data exclusivity, and potential pediatric or orphan-drug designations.
3. How does pricing differ between biologics and small molecules?
Biologics often price higher due to complex manufacturing and the barriers to biosimilar entry, with prices above $8,000 per dose.
4. What is the typical timeline for market entry in emerging markets?
Usually 2-4 years after initial approval in the US or EU, contingent on regulatory processes.
5. How do reimbursement policies influence pricing?
Reimbursement levels set by payers determine the maximum allowable price, influencing market penetration and revenue.
References
[1] U.S. Food and Drug Administration. (2021). Approved Biological Products.
[2] IQVIA. (2022). The Global Use of Medicines Report.
[3] Evaluate Pharma. (2022). World Preview 2022: Outlook to 2027.
[4] Congressional Research Service. (2020). Biosimilar Drug Development and Market Dynamics.
[5] Grand View Research. (2023). Biologics Market Size, Share & Trends.
